Klaria Pharma’s CEO increases his holdings of the company’s shares with purchases of over SEK 1 million
Klaria Pharma Holding AB (publ) announces that its CEO Jesper Wiklund has increased his holdings in shares of the company in the previous six months by acquiring 176,984 shares at a cost of 1,015,355 SEK. Additionally, Klaria’s board member Anders Ardstål has acquired 40,000 Klaria shares.
All board members of Klaria are shareholders in the company. Klaria’s CSO and board member Scott Boyer holds 725,010 shares in the company and board member Björn Littorin owns 72,000 shares.
